Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1970 Nov;19(5):799-807.

Enhanced vascular permeability induced in mice by larch arabinogalactan

Enhanced vascular permeability induced in mice by larch arabinogalactan

L S Kind et al. Immunology. 1970 Nov.

Abstract

Larch arabinogalactan AG(Lch) enhances vascular permeability when injected into normal mice. Increased vascular permeability is demonstrated by a marked blueing of the ears (BE) which follows the intravenous administration of AG(Lch) and Evans's blue dye. BE can be inhibited by D-galactose, derivatives of D-galactose, and oligosaccharides which contain D-galactose. The stereochemical specificity of inhibition, the specificity of desensitization of mice to AG(Lch) by repeated injections of this polysaccharide and the rapid elimination of [3H]AG(Lch) from the circulation, suggest that AG(Lch) may produce its biological effects by interacting with natural antibody. In vitro oxidation of the terminal non-reducing galactose residues of AG(Lch) by galactose oxidase completely destroys the ear blueing capacity of AG(Lch). BE induced by AG(Lch) in mice resembles anaphylactoid oedema elicited by dextran in rats in that it can be inhibited by the administration of (a) an anti-serotonin drug (UML 491), and (b) a hyperglycaemic inducing agent (alloxan). As in the dextran system in rats, a strain of mice has been found which does not react to AG(Lch).

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am J Physiol. 1959 Aug;197:377-9 - PubMed
    1. Br J Pharmacol Chemother. 1968 Jun;33(2):304-11 - PubMed
    1. Adv Immunol. 1966;5:1-28 - PubMed
    1. J Exp Med. 1964 Nov 1;120:897-924 - PubMed
    1. Proc Soc Exp Biol Med. 1964 Nov;117:565-7 - PubMed

MeSH terms

LinkOut - more resources